Top Tweets for #beatAML
AML isn't one disease. New Beat AML® data show that treatment length may need to depend on a patient's genetics, not a one-size-fits-all approach.
Read more 🔎
https://t.co/EjuzUM8Jfa
#BeatAML #AMLResearch
@beatalleukemia @OSUCCC_James
I couldn’t be more proud to have @beatalleukemia lead the amazing Opti-AML trial for #BeatAML and for the amazing presentation at #EHA2026!
@bcutd_research
Super proud of @beatalleukemia for delivering a fantastic presentation of the OPTI-AML data showing that Aza/Ven-14 is NOT equivalent to Aza/Ven-28 days at least for induction cycles 1-2. Highly impactful study from our BEAT AML team @bcutd_research
Research from @FiekeHoff at @NIH is using real-world data from the #BeatAML trial to understand how RAS gene mutations influence outcomes for patients with AML who also have NPM1 mutations. Dive into the research at #ASH25 👉 https://t.co/rdDjGnpgcD
Congratulations to Dr. John Byrd, recipient of our Excellence in Scientific Service Award! 👏
Dr. Byrd has worked extensively with Blood Cancer United as Chief Medical Officer of the #BeatAML Master Clinical Trial. He also sits on the Advisory Council that provides oversight and guidance on the Therapy Acceleration Program (TAP).
#ASH25
Congrats John Byrd on your #BloodCancerUnited Excellence in scientific service award! You have dedicated so much to Blood Cancer United, Beat AML and all your patients. Truly honored to work alongside you in the fight against blood cancer ❤️
@BloodCancerUtd #BeatAML
Emily Curran, of @UCincyMedicine, is presenting a trial-in-progress poster from a #BeatAML sub-study at #ASH25 looking at how well ficlatuzumab with azacitidine/venetoclax works in patients with AML. Intrigued? Learn more 👉 https://t.co/rdDjGnpgcD #ASH25
Working #ash2025 to spread the work of #beataml #bloodcancerunited . A special thanks to all our investigators presenting data this year - @FiekeHoff @CLachowiez and Emily Curran. ❤️❤️❤️❤️
🤝 We are expanding our partnership with @LLSusa to save lives faster.
💡 Building on our previous collaboration, we’re automating Patient Narratives, TLFs, and CSRs for the BAML clinical studies.
#AI #ClinicalTrials #LifeSciences #BeatAML
https://t.co/WV6f25G1fM
Presenters Mona Stefanos and @beatalleukemia of @OSUCCC_James share exciting findings from our #BeatAML ven/aza subtrial! 🩸✨ New data highlights the early success of targeted therapies in newly diagnosed older #AML patients, showcasing the need for more of these treatments to achieve similar survival outcomes while improving quality of life. 🌟 #ASH24 @ASH_hematology
🚨 Live from #ASH24! @FiekeHoff of @nih_nhlbi shares new results from one of our #BeatAML subtrials on how lower-intensity therapy shows favorable outcomes for newly diagnosed older #AML patients with IDH2 mutations. 💡 @ASH_hematology #AMLsm
Hopeful update 🚨 Data from one of our #BeatAML subtrials with @beatalleukemia of @OSUCCC_James at #ASH24 shows the use of specific therapies in older adult #AML patients with certain genetic mutations is associated with better overall survival. This will help inform future clinical trials. 💡@ASH_hematology #leusm
It’s a beautiful day at #ASH24, and we’re looking forward to celebrating the incredible advancements coming from our #BeatAML subtrials poster from @beatalleukemia! 👏🩸 @ASH_hematology
Happy SaASHurday #ASH24 attendees in Sunny San Diego - what are you excited to attend this am ?I’m a myeloid malignancy enthusiast so will be taking in multiple AML sessions on FL therapy, Ven resistance & the AML M&M education session discussing MRD . Happy ASH! @beatalleukemia
Please give generously in memory of Ellie and to help the inspirational Bray family raise money to #beatAML @bloodcancer_uk #AllforEllie
https://t.co/jGkKcgBGNc
Jo (not on X yet!) does an amazing job as part of
@DCGResearch @BLSCardiffUni and we are lucky to have her. Looking forward to see how her leadership impacts @CardiffEcmc over the next several years 👏 #beatAML
Over 200 patients have willingly signed up for this study since we opened it @CV_UHB making it one of our busiest studies.patients ability to help others in times of crisis is truly humbling 🙏
Agree- such an important issue impacting clinical practice. But we need prospective data to guide these decisions. The OPTI-AML trial led by @beatalleukemia funded by @LLSusa #BEATAML is investigating whether Aza/Ven x 14 days is = Aza/Ven x 28 days. https://t.co/D8xFeTZU4F
IMO, one of the most important articles of 2023 - gives us room to reduce venetoclax in future studies using HMA/ven backbones.
14 v. 21 v. 28 day venetoclax w/ HMA in newly diagnosed AML
https://t.co/WaoKbof6Rc
@FiekeHoff (poster 4296) & @beatalleukemia (poster 4332) will present their Beat AML® Master Clinical Trial findings tonight in halls G-H. #BeatAML has shown improved survival and quality of life for #BloodCancer patients.🩸#ASH23
Last Seen Hashtags on Sotwe
cap d'agde
propagule
Seen from United States
BodyguardBBC
Seen from United States
clydeexplorer
Seen from United States
xlii or nolimit or momson() +filter:native_video
Seen from Argentina
RGETemple
Seen from United States
İstanbul
Seen from Turkey
Qetl
Seen from United States
首绞
Seen from Japan
nolimit()**************************** momson()***************** filter:native_video
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.1M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers